0115-1329 NDC - DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE ()

Drug Information

Product NDC: 0115-1329

Proprietary Name: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Global Pharmaceuticals, Division of Impax Laboratories Inc.
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:12/17/2013

Package Information

No. Package Code Package Description Billing Unit
10115-1329-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1329-01)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0115-1329The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEDextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE12/17/2013This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEGlobal Pharmaceuticals, Division of Impax Laboratories Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023